Cluster Headache Treatment Survey
NCT06011811 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2487
Last updated 2026-02-18
Summary
The objective of this study is to survey patients with cluster headache about treatment effectiveness and their views on treatments. Participants will complete one brief questionnaire online.
Conditions
- Cluster Headache
Sponsors & Collaborators
-
Clusterbusters, Inc.
collaborator UNKNOWN -
The University of Texas Health Science Center, Houston
lead OTHER
Principal Investigators
-
Mark J Burish, MD, PhD · The University of Texas Health Science Center, Houston
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-29
- Primary Completion
- 2025-06-28
- Completion
- 2025-06-28
Countries
- United States
Study Locations
More Related Trials
-
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
NCT02168764 ·Status: UNKNOWN ·Phase: NA
-
Exploring Clinical Trial Experiences of Patients With Migraine
NCT05675189 ·Status: NOT_YET_RECRUITING
-
Retrospective Study on the Use of CEFALY® Device During Migraine Attacks
NCT02616978 ·Status: COMPLETED
-
A Research Study to Examine Cutaneous Allodynia and Cluster Headache
NCT00329836 ·Status: COMPLETED
-
New Daily Persistent Headache Survey
NCT05984719 ·Status: COMPLETED
-
Efficacy of Erenumab in Chronic Cluster Headache
NCT04970355 ·Status: COMPLETED ·Phase: PHASE2
-
Risk Taking and Decision-making in Cluster Headache Patients
NCT06410872 ·Status: COMPLETED
-
Double-Blind Comparison of the Efficacy and Safety of C213 to Placebo for the Acute Treatment of Cluster Headaches
NCT04066023 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Role of Specific microRNAs in Cluster Headache
NCT06503328 ·Status: RECRUITING
-
A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH)
NCT05064397 ·Status: COMPLETED ·Phase: PHASE3
-
SPG Neurostimulation in Cluster Patients
NCT02510729 ·Status: COMPLETED ·Phase: NA
-
Ketamine + Magnesium for Chronic Cluster Headache (KETALGIA)
NCT04814381 ·Status: COMPLETED ·Phase: PHASE4
-
PACAP-38 Infusion in Patients With Cluster Headache
NCT03814226 ·Status: UNKNOWN ·Phase: NA
-
Sphenopalatine Ganglion Stimulation for the Acute Treatment of Cluster Headache
NCT01255813 ·Status: COMPLETED ·Phase: NA
-
Treatment of Episodic Migraine With AURICular Neuromodulation
NCT06623188 ·Status: RECRUITING ·Phase: NA
-
Cluster Headache Treatment With Rimegepant
NCT05264714 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Galcanezumab in Participants With Chronic Cluster Headache
NCT02438826 ·Status: COMPLETED ·Phase: PHASE3
-
CGRP's Cluster Headache Inducing Abilities in Cluster Headache Patients
NCT02466334 ·Status: COMPLETED ·Phase: NA
-
Pilot Study Evaluating the Use of Nasal Carbon Dioxide for the Treatment of Cluster Headache
NCT02381795 ·Status: TERMINATED ·Phase: PHASE2
-
Determining the Utility of a Behavioral Intervention in Chronic Migraine
NCT05415020 ·Status: RECRUITING ·Phase: NA
-
Quantitative Sensory Testing and Occipital Nerve Stimulator
NCT06022848 ·Status: COMPLETED ·Phase: NA
-
Sleep, Circadian Rhythms and Cluster Headache
NCT01447641 ·Status: COMPLETED
-
Study of Hypothalamic Metabolism in Spontaneous Cluster Headache Attacks
NCT00458770 ·Status: TERMINATED ·Phase: NA
-
The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients
NCT04452929 ·Status: UNKNOWN ·Phase: NA
-
mBrain-21 : a Three-month Study on Context-awareness, Physiological Monitoring, and Machine Learning in Migraine and Cluster Headache
NCT04983186 ·Status: COMPLETED ·Phase: NA